Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 11, 2024
Evaluation of Sonographic Muscle Measurement Using Established Muscle MarkersWolfgang Maximilian Kremer, Alexander Schwarz, Markus Schepers, et al.
Scientific Reports|June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIVMaurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
The American Journal of Gastroenterology|March 9, 2019
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With CirrhosisChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Hepatology Communications|May 14, 2025
Letter to the editor: Refining risk stratification in hepatic encephalopathy-External validation of the BABS score in European cohortsNadja G Østberg, Gabriele Berg-Beckhoff, Lea L Grønkjær, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Management of hepatic encephalopathy in Germany: a survey among physiciansChristian Labenz, Charles C Adarkwah, Marcus-Alexander Wörns, et al.
Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.
Journal of Hepatology|March 21, 2025
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryEva Maria Schleicher, Henrik Karbannek, Julia Weinmann-Menke, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 11, 2024
Evaluation of Sonographic Muscle Measurement Using Established Muscle MarkersWolfgang Maximilian Kremer, Alexander Schwarz, Markus Schepers, et al.
Scientific Reports|June 6, 2023
Metabolic dysfunction-associated fatty liver disease in people living with HIVMaurice Michel, Christian Labenz, Angelo Armandi, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 10, 2020
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infectionChristian Labenz, Wolfgang M Kremer, Jörn M Schattenberg, et al.
Clinical and Translational Gastroenterology|June 23, 2020
Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing StrategiesChristian Labenz, Gerrit Toenges, Jörn M Schattenberg, et al.
The American Journal of Gastroenterology|March 9, 2019
Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With CirrhosisChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Alimentary Pharmacology & Therapeutics|October 5, 2019
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyChristian Labenz, Gerrit Toenges, Yvonne Huber, et al.
Hepatology Communications|May 14, 2025
Letter to the editor: Refining risk stratification in hepatic encephalopathy-External validation of the BABS score in European cohortsNadja G Østberg, Gabriele Berg-Beckhoff, Lea L Grønkjær, et al.
Zeitschrift Fur Gastroenterologie|January 14, 2020
Management of hepatic encephalopathy in Germany: a survey among physiciansChristian Labenz, Charles C Adarkwah, Marcus-Alexander Wörns, et al.
Digestive Diseases (Basel, Switzerland)|July 5, 2017
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibChristian Labenz, Vera Prenosil, Sandra Koch, et al.
Journal of Hepatology|March 21, 2025
Effect of albumin treatment duration on response rates and outcomes in patients with cirrhosis and acute kidney injuryEva Maria Schleicher, Henrik Karbannek, Julia Weinmann-Menke, et al.
Pageof 15